Skip to main content

Biopharma Startups

Updated August 2026

Companies in the biopharma sector developing innovative solutions and technologies.

Explore 885 recently funded biopharma companies with verified founder contact information and fundraising data.

Total Companies
885
Total Funding
$1.1B
Avg Funding
$43.8M
Global Reach
7
countries

Top Cities for Biopharma

Tokyo
New York
Cardiff
San Francisco
Cambridge
Los Altos

Recently Funded Companies

Export
Tokyo, Japan

Renalys Pharma is a clinical-stage biopharmaceutical company developing therapeutics for renal disease in Asian patients.

$38.5M raised
Jul 2024

Founder Contacts

41,000+ verified contacts

New York, United States

Cambrian is a distributed development company building therapeutics to lengthen health span.

$123.8M raised
Jul 2026

Founder Contacts

41,000+ verified contacts

Cardiff, United Kingdom

Draig Therapeutics is a clinical-stage biopharmaceutical company that develops investigational therapies for neuropsychiatric disorders.

$65.0M raised
Jul 2026

Founder Contacts

41,000+ verified contacts

San Francisco, United States

Felix Biotechnology is working to accelerate the deployment of novel biotherapeutics to manage infectious diseases.

$314K raised
Jul 2022

Founder Contacts

41,000+ verified contacts

Cambridge, United States

Imara is provider of novel therapeutics for the people living with sickle cell disease and hemoglobinopathies.

$50.0M raised
Jul 2021

Founder Contacts

41,000+ verified contacts

Los Altos, United States

Alto Neuroscience is a clinical-stage biopharmaceutical company that creates precision medicines through its AI-driven biomarker platform.

$100.0M raised
Jul 2026

Founder Contacts

41,000+ verified contacts

Morristown, United States

B1 Health offers a platform for clinical trial design optimization, documentation, process tracking & insight generation for biotech firms.

$350K raised
Jul 2026

Founder Contacts

41,000+ verified contacts

Cambridge, United Kingdom

Healx is a rare disease biotechnology company that uses generative AI for drug discovery.

Jul 2025

Founder Contacts

41,000+ verified contacts

San Francisco, United States

Enabling immune infiltration of the tumor microenvironment

Jul 2023

Founder Contacts

41,000+ verified contacts

Caledon, Canada

Algae-C is a biotechnology company.

$301K raised
Jul 2022

Founder Contacts

41,000+ verified contacts

Concord, United States

Kantum Pharma is developing a specific AKI therapy to help critical care clinicians prevent hundreds of thousands of deaths from AKI.

$3.5M raised
Jul 2021

Founder Contacts

41,000+ verified contacts

Creve Coeur, United States

Intact Genomics provides high-quality life science products and large DNA fragment cloning related services

$2.9M raised
Jul 2022

Founder Contacts

41,000+ verified contacts

Gisborne, New Zealand

Rua Bioscience develops medicinal cannabis products.

$262K raised
Jul 2021

Founder Contacts

41,000+ verified contacts

Watertown, United States

Dynamic Cell Therapies develops controllable CAR T cells for the treatment of cancers.

$1.0M raised
Jul 2024

Founder Contacts

41,000+ verified contacts

Durham, United States

Growth Curve Bio is a biotechnology company.

$3.5M raised
Jul 2024

Founder Contacts

41,000+ verified contacts

Gerasdorf Bei Wien, Austria

Fermify - universally accessible sustainable food proteins

$1.7M raised
Jul 2023

Founder Contacts

41,000+ verified contacts

Birmingham, United Kingdom

FourPlus Immersive offer immersive software solutions for the life sciences sector, including skills & facility mapping & recruitment tools.

$1.3M raised
Jul 2023

Founder Contacts

41,000+ verified contacts

Cambridge, United States

City Therapeutics is a biopharmaceutical company focused on developing RNA interference (RNAi)-based medicines for a range of diseases.

$99.5M raised
Jun 2026

Founder Contacts

41,000+ verified contacts

New York, United States

Elevation Oncology is a clinical-stage biopharmaceutical company focused on the development of precision medicines for patients.

$50.0M raised
Jun 2023

Founder Contacts

41,000+ verified contacts

Marlborough, United States

Akoya Biosciences is a spatial biology company offering solutions for high-parameter tissue analysis from biomarker discovery to validation.

$43.5M raised
Jun 2023

Founder Contacts

41,000+ verified contacts

Zürich, Switzerland

Invasight is a clinical biotech company that focused on revolutionizing cell invasion research.

$4.6M raised
Jun 2022

Founder Contacts

41,000+ verified contacts

New York, United States

Aclid is a biotechnology security and compliance automation platform.

$3.3M raised
Jun 2023

Founder Contacts

41,000+ verified contacts

Milwaukee, United States

Ten Bay Bio is a biotechnology company that offers biological therapies for treatment of complex diseases in immunology.

$500K raised
Jun 2025

Founder Contacts

41,000+ verified contacts

Wilmington, United States

Liminatus Pharma is a immuno‑oncology company offering CD47‑blockade antibody solutions to prevent anemia and thrombocytopenia.

$1.9M raised
Jun 2026

Founder Contacts

41,000+ verified contacts

Radnor, United States

Mineralys Therapeutics is a clinical-stage biopharmaceutical company committed to developing therapy for the treatment of hypertension.

$500.0M raised
Jun 2026

Founder Contacts

41,000+ verified contacts

Showing 126 to 150 of 885 companies

About the Biopharma Startup Ecosystem

The biopharma sector is an active area of startup innovation and venture capital investment. Companies in this space are developing new technologies, platforms, and services that address evolving market needs and create new business opportunities.

Funding Trends in Biopharma

Biopharma companies raise capital across various funding stages, from early seed rounds to late-stage growth financing. Investor interest in this sector is driven by the size of the addressable market, the pace of technology adoption, and the potential for scalable business models.

Growth Outlook

The biopharma sector is expected to continue evolving as technology advances, market dynamics shift, and new opportunities emerge. Companies that demonstrate strong product-market fit, efficient growth, and clear competitive advantages are well-positioned to attract continued investment.

Biopharma Funding Breakdown

Here is how funding is distributed among the 885 biopharma companies tracked in the VCBacked database.

Average Funding
$43.8M
Total Funding Tracked
$1.1B
Countries Represented
7

Distribution by Funding Stage

Other25 companies

Top Cities for Biopharma

1.New York
3 companies$177.1M
2.Cambridge
3 companies$149.5M
3.San Francisco
2 companies$314K
4.Tokyo
1 companies$38.5M
5.Cardiff
1 companies$65.0M

Related Industries

Companies in the biopharma sector often overlap with or complement businesses in adjacent industries. Exploring related verticals can help you discover additional companies, identify partnership opportunities, and understand the broader competitive landscape.

Ready to Connect with Biopharma Startups?

Perfect for: B2B sales teams targeting biopharma companies, investors exploring sector opportunities, and service providers looking for funded companies ready to scale.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked